Page last updated: 2024-08-23

bromocriptine and vasoactive intestinal peptide

bromocriptine has been researched along with vasoactive intestinal peptide in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19907 (38.89)18.7374
1990's9 (50.00)18.2507
2000's2 (11.11)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Makowska, A; Soszyński, P; Słowińska-Srzednicka, J; Zgliczyński, S; Zgliczyński, W1
Bloom, SR; Ghatei, MA; Jones, PM; O'Halloran, DJ1
Ichikawa, Y; Usuki, S1
Gala, RR; Haisenleder, DJ; Lawson, DM; Moy, JA2
Day, RN; Hinkle, PM1
Jenkins, JS; Prysor-Jones, RA; Silverlight, JJ1
Collu, R; Ducharme, JR; Eljarmak, D; Lafond, J; Marchisio, AM1
Dimaline, R; Graham, K; Lightman, SL; McGarrick, G; Unwin, RJ1
Blomquist, L; Goiny, M; Posloncec, B; Uvnäs-Moberg, K1
Tamura, T; Watanobe, H1
Carrillo, AJ; Liu, B; Signs, SA; Wolford, J1
Sasaki, S; Takebe, K; Tamura, T; Watanobe, H1
Alberici, A; Memo, M; Spano, P; Tinti, C; Valerio, A1
Bende, M; Bergman, B; Sjögren, C1
Balsa, JA; Cacicedo, L; Lara, JI; Lorenzo, MJ; Pazos, F; Sánchez-Franco, F1
Bjøro, T; Gautvik, KM; Gordeladze, JO; Johansen, PW; Paulssen, RH1
Balsa, JA; Gómez, O1

Trials

1 trial(s) available for bromocriptine and vasoactive intestinal peptide

ArticleYear
Vasoactive intestinal polypeptide stimulation of prolactin release and renin activity in normal man and patients with hyperprolactinaemia: effects of pretreatment with bromocriptine and dexamethazone.
    European journal of clinical investigation, 1984, Volume: 14, Issue:6

    Topics: Adenoma; Adult; Bromocriptine; Dexamethasone; Female; Heart Rate; Hematocrit; Humans; Male; Pituitary Neoplasms; Prolactin; Renin; Vasoactive Intestinal Peptide

1984

Other Studies

17 other study(ies) available for bromocriptine and vasoactive intestinal peptide

ArticleYear
Increased plasma VIP concentration in patients with prolactinoma.
    Endokrynologia Polska, 1992, Volume: 43, Issue:3

    Topics: Adult; Analysis of Variance; Bromocriptine; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Vasoactive Intestinal Peptide

1992
Rat anterior pituitary neuropeptides following chronic prolactin manipulation: a combined radioimmunoassay and mRNA study.
    The Journal of endocrinology, 1991, Volume: 131, Issue:3

    Topics: Animals; Blotting, Northern; Bromocriptine; Female; Galanin; Haloperidol; Hypothalamus; Neuropeptides; Peptides; Pituitary Gland, Anterior; Prolactin; Radioimmunoassay; Rats; Rats, Inbred Strains; RNA, Messenger; Substance P; Vasoactive Intestinal Peptide

1991
Effects of hachimijiogan on dopamine, serotonin and vasoactive intestinal peptide in plasma and hypothalamus in sulpiride-induced hyperprolactinemic rats.
    The American journal of Chinese medicine, 1991, Volume: 19, Issue:3-4

    Topics: Animals; Bromocriptine; Dopamine; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Female; Hyperprolactinemia; Hypothalamus; Rats; Rats, Inbred Strains; Serotonin; Sulpiride; Vasoactive Intestinal Peptide

1991
The effects of transient dopamine antagonism on thyrotropin-releasing hormone-induced prolactin release in pseudopregnant rats.
    Endocrinology, 1986, Volume: 119, Issue:5

    Topics: Animals; Bromocriptine; Domperidone; Dopamine Antagonists; Female; Hysterectomy; Prolactin; Pseudopregnancy; Rats; Thyrotropin-Releasing Hormone; Time Factors; Vasoactive Intestinal Peptide

1986
The effect of dopamine antagonists and/or VIP on TRH- or VIP-induced prolactin release in estrogen- and progesterone-treated ovariectomized rats.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1988, Volume: 187, Issue:3

    Topics: Animals; Bromocriptine; Domperidone; Dopamine Antagonists; Drug Synergism; Estradiol; Female; Ovariectomy; Progesterone; Prolactin; Rats; Rats, Inbred Strains; Sulpiride; Thyrotropin-Releasing Hormone; Vasoactive Intestinal Peptide

1988
Transient dopaminergic inhibition of prolactin release from hybrid cells derived by fusion of normal rat pituitary and GH4C1 tumor cells.
    Endocrinology, 1988, Volume: 122, Issue:5

    Topics: Animals; Bromocriptine; Cell Fusion; Cell Line; Cells, Cultured; Dopamine; Female; Growth Hormone; Hybrid Cells; Pituitary Gland; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred WF; Spiperone; Thyrotropin-Releasing Hormone; Vasoactive Intestinal Peptide

1988
Hyperprolactinemia reduces vasoactive intestinal peptide in the anterior pituitary glands of rats.
    Neuroscience letters, 1987, Oct-05, Volume: 80, Issue:3

    Topics: Animals; Bromocriptine; Drug Implants; Estradiol; Female; Fluphenazine; Hyperprolactinemia; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains; Vasoactive Intestinal Peptide

1987
Sodium ions: their role and mechanism of action in the control of prolactin release.
    Endocrinology, 1984, Volume: 114, Issue:4

    Topics: Animals; Bromocriptine; Cells, Cultured; Cobalt; Dopamine; Female; Haloperidol; Ouabain; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains; Sodium; Tetrodotoxin; Thyrotropin-Releasing Hormone; Vasoactive Intestinal Peptide; Veratridine

1984
Increased levels of VIP (vasoactive intestinal polypeptide)-like immunoreactivity in peripheral venous blood of dogs following injections of apomorphine and bromocriptine. Do dopaminergic agents induce gastric relaxation and hypotension by a release of en
    Acta physiologica Scandinavica, 1982, Volume: 115, Issue:3

    Topics: Animals; Apomorphine; Bromocriptine; Dogs; Gastrointestinal Hormones; Gastrointestinal Motility; Haloperidol; Hypotension; Muscle Relaxation; Receptors, Dopamine; Vasoactive Intestinal Peptide; Vomiting

1982
Clinical significance of the growth hormone response to vasoactive intestinal peptide and gonadotropin-releasing hormone in acromegaly.
    Neuropeptides, 1995, Volume: 28, Issue:2

    Topics: Acromegaly; Adult; Aged; Bromocriptine; Dose-Response Relationship, Drug; Female; Gonadotropin-Releasing Hormone; Growth Hormone; Humans; Male; Middle Aged; Thyrotropin-Releasing Hormone; Vasoactive Intestinal Peptide

1995
Serotonergic involvement in the regulation of prolactin and vasoactive intestinal peptide mRNA expression in the rat anterior pituitary.
    Molecular and cellular endocrinology, 1994, Volume: 105, Issue:2

    Topics: 5-Hydroxytryptophan; alpha-Methyltyrosine; Animals; Blotting, Northern; Bromocriptine; Gene Expression Regulation; Haloperidol; Ketanserin; Male; Methiothepin; Methoxydimethyltryptamines; Methyltyrosines; Pituitary Gland, Anterior; Prolactin; Quipazine; Rats; Rats, Sprague-Dawley; RNA, Messenger; Serotonin; Time Factors; Transcription, Genetic; Vasoactive Intestinal Peptide

1994
Contradictory clinical implications between paradoxical growth hormone responses to thyrotropin-releasing hormone and those to vasoactive intestinal peptide and luteinizing hormone-releasing hormone in acromegaly.
    Neuropeptides, 1993, Volume: 25, Issue:6

    Topics: Acromegaly; Adult; Bromocriptine; Female; Gonadotropin-Releasing Hormone; Growth Hormone; Humans; Male; Middle Aged; Prolactin; Sex Characteristics; Thyrotropin-Releasing Hormone; Vasoactive Intestinal Peptide

1993
Antisense strategy unravels a dopamine receptor distinct from the D2 subtype, uncoupled with adenylyl cyclase, inhibiting prolactin release from rat pituitary cells.
    Journal of neurochemistry, 1994, Volume: 62, Issue:4

    Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Base Sequence; Bromocriptine; Cells, Cultured; Cyclic AMP; Female; Molecular Sequence Data; Oligonucleotides, Antisense; Pituitary Gland, Anterior; Polymerase Chain Reaction; Prolactin; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; RNA, Messenger; Spiperone; Vasoactive Intestinal Peptide

1994
Nasal mucosal congestion after treatment with bromocriptine.
    The Laryngoscope, 1993, Volume: 103, Issue:10

    Topics: Adult; Airway Resistance; Bromocriptine; Estradiol; Female; Humans; Lactation; Nasal Cavity; Nasal Mucosa; Progesterone; Prolactin; Thyrotropin; Vasoactive Intestinal Peptide; Vasodilation

1993
Autoparacrine action of vasoactive intestinal peptide on dopaminergic control of prolactin secretion.
    Endocrinology, 1996, Volume: 137, Issue:2

    Topics: Animals; Bromocriptine; Cells, Cultured; Dopamine; Gene Expression; Humans; Male; Pituitary Gland, Anterior; Prolactin; Rats; Receptors, Vasoactive Intestinal Peptide; RNA, Messenger; Triiodothyronine; Vasoactive Intestinal Peptide

1996
Distinct guanine nucleotide binding protein alpha-subunit receptor coupling in GH cell lines: effects of bromocriptine and hormones on effector enzyme modulation.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2001, Volume: 11, Issue:6

    Topics: Adenylyl Cyclases; Animals; Bromocriptine; Cell Line; Cell Membrane; Dopamine Agonists; Heterotrimeric GTP-Binding Proteins; Immune Sera; Phosphotransferases (Alcohol Group Acceptor); Pituitary Gland; Prolactin; Rats; Receptors, Dopamine D2; Reverse Transcriptase Polymerase Chain Reaction; Thyrotropin-Releasing Hormone; Type C Phospholipases; Vasoactive Intestinal Peptide

2001
Implication of pituitary vasoactive intestinal peptide in dopaminergic inhibition of estrogen-induced pituitary hyperplasia and vascular endothelial growth factor expression.
    Neuroendocrinology, 2004, Volume: 80, Issue:5

    Topics: Animals; Blotting, Northern; Blotting, Western; Brain; Bromocriptine; Diethylstilbestrol; Dopamine; Dopamine Agonists; Estrogens, Non-Steroidal; Female; Hyperplasia; Pituitary Gland; Prolactin; Rats; Rats, Inbred F344; Receptors, Vasoactive Intestinal Peptide; RNA, Messenger; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A; Vasoactive Intestinal Peptide

2004